Peter Max Smid

Title: The Innovations of Peter Max Smid

Introduction

Peter Max Smid is a notable inventor based in Delft, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial compounds. His work has led to the creation of innovative solutions that address critical health challenges.

Latest Patents

Peter Max Smid holds a patent for 7-[3-Substituted isoxazol-5-yl]-acetamido-cephalosporanic acids. This patent also includes novel heterocyclic amides with various substituents that enhance their antibacterial properties. The compounds he developed are characterized by their complex structures and potential therapeutic applications.

Career Highlights

Peter Max Smid is associated with Koninklijke Nederlandsche Gist-en Spiritusfabriek N.V., a company known for its advancements in biotechnology and pharmaceuticals. His work at this institution has allowed him to focus on innovative research and development in the field of medicinal chemistry.

Collaborations

Peter Max Smid has collaborated with his coworker, Peter W. Henniger, to further enhance the research and development of their patented compounds. Their partnership has contributed to the advancement of their projects and the exploration of new therapeutic avenues.

Conclusion

Peter Max Smid's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the development of antibacterial agents, showcasing the importance of innovation in healthcare.